AstraZeneca Profit Falls on Generic Competition

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Feb. 6 (Bloomberg) -- AstraZeneca said fourth-quarter profit fell as sales of its best-selling medicines and growth in emerging markets failed to compensate for increasing generic competition. Anna Edwards reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change